These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30139738)

  • 1. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
    Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
    Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
    Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
    Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
    Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
    Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
    Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
    Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
    Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
    Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
    Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
    French CA
    Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
    Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
    Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
    Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
    Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
    J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
    Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
    Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
    French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
    Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
    Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
    Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
    Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
    Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
    French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
    Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.
    Wang R; You J
    J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
    Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA
    Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recurrent novel
    Diolaiti D; Dela Cruz FS; Gundem G; Bouvier N; Boulad M; Zhang Y; Chou AJ; Dunkel IJ; Sanghvi R; Shah M; Geiger H; Rahman S; Felice V; Wrzeszczynski KO; Darnell RB; Antonescu CR; French CA; Papaemmanuil E; Kung AL; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30552129
    [No Abstract]   [Full Text] [Related]  

  • 19. Supercharging BRD4 with NUT in carcinoma.
    Eagen KP; French CA
    Oncogene; 2021 Feb; 40(8):1396-1408. PubMed ID: 33452461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
    Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
    Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.